GGrantIndex
← Leaderboards

Elias Dakwar

New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc

$9,906,648
Attributed
$9,906,648
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $2.1M · FY201122
$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$9,906,648 · 6

By mechanism

R01$5,353,910 · 2
U01$2,770,261 · 1
K23$930,960 · 1
R21$851,517 · 2

Top collaborators

No co-investigators on record.

Most similar at New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc

Same institution · by research overlap

Others in their field

Top investigators on “Abstinence

Research focus

AbstinencePharmaceutical PreparationsRandomizedKetamineGlutamatesAffinityInfusion ProceduresAnestheticsPharmacotherapyN-Methyl-D-Aspartate ReceptorsInpatientsCocaineCocaine UsersCuesMindfulnessDisorder Later Incidence PreventionDrug UsageBaseActive ControlDoseMidazolamHourClinical TrialsCraving

Grant awards (21)

The role of brief potent glutamatergic modulation in addressing problem drinking: a randomized, controlled trial$708,284
R01 · FY2022 · AA · contact PI
The role of brief potent glutamatergic modulation in addressing problem drinking: a randomized, controlled trial$708,284
R01 · FY2021 · AA · contact PI
The role of brief potent glutamatergic modulation in addressing problem drinking: a randomized, controlled trial$708,284
R01 · FY2020 · AA · contact PI
Pharmacological Facilitation of Behavioral Modification for Cocaine Use Disorders$695,715
U01 · FY2020 · DA · contact PI
Glutamatergic Modulation to Facilitate Naltrexone Initiation: A Randomized, Controlled Trial$619,990
R01 · FY2020 · DA · contact PI
The role of brief potent glutamatergic modulation in addressing problem drinking: a randomized, controlled trial$743,120
R01 · FY2019 · AA · contact PI
Pharmacological Facilitation of Behavioral Modification for Cocaine Use Disorders$690,016
U01 · FY2019 · DA · contact PI
Glutamatergic Modulation to Facilitate Naltrexone Initiation: A Randomized, Controlled Trial$625,093
R01 · FY2019 · DA · contact PI
Pharmacological Facilitation of Behavioral Modification for Cocaine Use Disorders$689,717
U01 · FY2018 · DA · contact PI
Glutamatergic Modulation to Facilitate Naltrexone Initiation: A Randomized, Controlled Trial$619,990
R01 · FY2018 · DA · contact PI
Pharmacological Facilitation of Behavioral Modification for Cocaine Use Disorders$694,813
U01 · FY2017 · DA · contact PI
Glutamatergic Modulation to Facilitate Naltrexone Initiation: A Randomized, Controlled Trial$620,865
R01 · FY2017 · DA · contact PI
The Effect of Brief Potent Glutamatergic Modulation on Disordered Alcohol Use$192,375
R21 · FY2016 · AA · contact PI
The Effect of Brief Potent Glutamatergic Modulation on Disordered Alcohol Use$232,875
R21 · FY2015 · AA · contact PI
Brief Potent Glutamatergic Modulation: Applications for Cocaine Dependence$186,192
K23 · FY2015 · DA · contact PI
The Effect of Glutamatergic Modulation on Cocaine Self-Administration$193,758
R21 · FY2014 · DA · contact PI
Brief Potent Glutamatergic Modulation: Applications for Cocaine Dependence$186,192
K23 · FY2014 · DA · contact PI
The Effect of Glutamatergic Modulation on Cocaine Self-Administration$232,509
R21 · FY2013 · DA · contact PI
Brief Potent Glutamatergic Modulation: Applications for Cocaine Dependence$186,192
K23 · FY2013 · DA · contact PI
Brief Potent Glutamatergic Modulation: Applications for Cocaine Dependence$186,192
K23 · FY2012 · DA · contact PI
Brief Potent Glutamatergic Modulation: Applications for Cocaine Dependence$186,192
K23 · FY2011 · DA · contact PI